B. G. Durie

Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients.

H. Garewal, B. Durie, Harinder S. Garewal, 2009, Scandinavian journal of haematology.

Primary amyloidosis associated with multiple myeloma. Predictors of successful therapy.

B. Durie, K. Fielder, Kathleen Fielder, 1986, The American journal of medicine.

In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.

S. Salmon, F. Meyskens, B. Durie, 1982, Cancer research.

Immunologic Aspects of the Hematologic Neoplasms.

B. G. Durie, Sydney E. Salmon, Stephen E. Jones, 1973, Postgraduate medicine.

Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.

S. Salmon, S. Jones, B. Durie, 1975, Cancer letters.

Cytogenetic analysis of leukaemic colonies from acute and chronic myelogenous leukaemia.

J. Trent, B. Durie, J. Davis, 1983, British Journal of Cancer.